Forest Laboratories will pay between $7.7 million and $10.4 million to settle multidistrict litigation alleging the drug company misled Missouri parents into buying Celexa and Lexapro for their children even though the antidepressants were not approved for children. The class includes all parents and other third parties in Missouri who purchased Celexa for a minor patient between Jan. 1, 1998, and Dec. 31, 2013, or Lexapro for a child between Aug. 1, 2002, and Dec. 31, 2013. Forest is accused of covering up clinical trial data that showed Celexa was ineffective in treating pediatric depression based on studies from as ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.